Cassandra Calabrese

3.5k total citations · 1 hit paper
63 papers, 1.5k citations indexed

About

Cassandra Calabrese is a scholar working on Infectious Diseases, Oncology and Hematology. According to data from OpenAlex, Cassandra Calabrese has authored 63 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 21 papers in Oncology and 13 papers in Hematology. Recurrent topics in Cassandra Calabrese's work include Cancer Immunotherapy and Biomarkers (18 papers), COVID-19 Clinical Research Studies (16 papers) and SARS-CoV-2 and COVID-19 Research (14 papers). Cassandra Calabrese is often cited by papers focused on Cancer Immunotherapy and Biomarkers (18 papers), COVID-19 Clinical Research Studies (16 papers) and SARS-CoV-2 and COVID-19 Research (14 papers). Cassandra Calabrese collaborates with scholars based in United States, Canada and France. Cassandra Calabrese's co-authors include Leonard H. Calabrese, Laura C. Cappelli, E. Kirchner, Jeffrey R. Curtis, Anne R. Bass, Apostolos Kontzias, Reuben J. Arasaratnam, Lindsey R. Baden, Ellen M. Gravallese and Rafael Harpaz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Infectious Diseases.

In The Last Decade

Cassandra Calabrese

57 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Moving towards personalized treatments of immune-related adverse events

2020 229 citations Cassandra Calabrese, Leonard H. Calabrese et al. profile →

Peers

Cassandra Calabrese

ONCOL

IMMUN

NEURO

RHEUM

Noha Abdel‐Wahab United States

Claire Galambrun France

Nicolas Noël France

Itziar Astigarraga Spain

Barbara Degar United States

Louis Letendre United States

Esa Jantunen Finland

Arcangelo Prete Italy

Susana Rives Spain

Inmaculada de la Torre Spain

Noha Abdel‐Wahab United States

Cassandra Calabrese

1.6k ×2.6

ONCOL

175 ×0.3

414 ×1.2

IMMUN

220 ×1.0

NEURO

194 ×0.9

RHEUM

Citations per year, relative to Cassandra Calabrese Cassandra Calabrese (= 1×) peers Noha Abdel‐Wahab

Countries citing papers authored by Cassandra Calabrese

Since Specialization

Citations

This map shows the geographic impact of Cassandra Calabrese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cassandra Calabrese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cassandra Calabrese more than expected).

Fields of papers citing papers by Cassandra Calabrese

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cassandra Calabrese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cassandra Calabrese. The network helps show where Cassandra Calabrese may publish in the future.

Co-authorship network of co-authors of Cassandra Calabrese

This figure shows the co-authorship network connecting the top 25 collaborators of Cassandra Calabrese. A scholar is included among the top collaborators of Cassandra Calabrese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cassandra Calabrese. Cassandra Calabrese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Calabrese, Cassandra, Abhijit Duggal, Yiying Fan, et al.. (2025). Effectiveness of Nirmatrelvir/Ritonavir or Molnupiravir Use in Immunocompromised Patients on B-Cell–Depleting Therapy With COVID-19: A Target Trial Emulation Study. Clinical Infectious Diseases. 81(6). 1065–1073.

Calabrese, Leonard H., Michael Putman, Jeffrey A. Sparks, et al.. (2025). The National Academies’ 2024 Diagnostic Criteria for Long COVID : Concerns That Could Affect the Rheumatology Community. Arthritis & Rheumatology. 77(7). 785–788.

Calabrese, Leonard H. & Cassandra Calabrese. (2024). Long COVID for the Rheumatologist. Rheumatic Disease Clinics of North America. 51(1). 29–43.

Calabrese, Cassandra, et al.. (2024). Imaging in Rheumatic Immune-related Adverse Events. Rheumatic Disease Clinics of North America. 50(2). 313–323.

Calabrese, Cassandra, et al.. (2024). Association between myeloid disorders and adult onset-inflammatory syndromes, successful treatment with JAK-inhibitors: Case series and literature review. Leukemia Research. 146. 107584–107584. 3 indexed citations

Braghieri, Lorenzo, Lubika J. Nkashama, Abdelrahman Ibrahim Abushouk, et al.. (2024). Long-Term Cardiovascular Outcomes of Immune Checkpoint Inhibitor-Related Myocarditis: A Large Single-Centre Analysis. ESC Heart Failure. 12(2). 1237–1245. 5 indexed citations

Calabrese, Cassandra, E. Kirchner, James Fernandez, & Leonard H. Calabrese. (2024). Preventing herpes zoster in immunocompromised patients: Current concepts. Cleveland Clinic Journal of Medicine. 91(7). 437–445. 5 indexed citations

Bass, Anne R., Noha Abdel‐Wahab, Pankti Reid, et al.. (2023). Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis. Annals of the Rheumatic Diseases. 82(7). 920–926. 39 indexed citations

López-Olivo, María A., Gabrielle F. Duhon, Mehmet Altan, et al.. (2023). Physician Views on the Provision of Information on Immune Checkpoint Inhibitor Therapy to Patients with Cancer and Pre-Existing Autoimmune Disease: A Qualitative Study. Cancers. 15(10). 2690–2690. 4 indexed citations

10.

Bass, Anne R., Noha Abdel‐Wahab, Pankti Reid, et al.. (2023). OP0029 COMPARATIVE SAFETY AND EFFECTIVENESS OF TNF INHIBITORS, IL6R INHIBITORS AND METHOTREXATE FOR THE TREATMENT OF IMMUNE CHECKPOINT INHIBITOR ASSOCIATED ARTHRITIS. Annals of the Rheumatic Diseases. 82. 19–19. 1 indexed citations

11.

Calabrese, Cassandra, et al.. (2023). Risk factors for severe COVID-19 among patients with systemic lupus erythematosus: a real-world analysis of a large representative US administrative claims database, 2020–2021. RMD Open. 9(3). e003250–e003250. 6 indexed citations

12.

Dikranian, Ara, Cassandra Calabrese, Clifton O. Bingham, et al.. (2023). AB0705 LONG TERM SAFETY OF CONVENTIONAL AND BIOLOGIC IL-6RI IMMUNOMODULATORS AS SECOND-LINE (2L) OR THIRD-LINE (3L) TREATMENT OF POLYMYALGIA RHEUMATICA. 1556–1557. 1 indexed citations

13.

Calabrese, Leonard H. & Cassandra Calabrese. (2022). Long COVID: defining the role of rheumatology in care and research. The Lancet Rheumatology. 4(12). e812–e814. 2 indexed citations

14.

Sullivan, James, et al.. (2021). COVID-19 Outcomes in Patients Undergoing B Cell Depletion Therapy and Those with Humoral Immunodeficiency States: A Scoping Review. SHILAP Revista de lepidopterología. 6(1). 76–103. 46 indexed citations

15.

Calabrese, Cassandra. (2021). Vaccinations in Patients with Rheumatic Disease. Medical Clinics of North America. 105(2). 213–225. 4 indexed citations

16.

Calabrese, Cassandra, et al.. (2021). The intersection of COVID-19 and autoimmunity: What is our current understanding?. SHILAP Revista de lepidopterología. 6(1). 31–54. 25 indexed citations

17.

Calabrese, Cassandra. (2020). COVID-19 and your rheumatology patients. Cleveland Clinic Journal of Medicine. 9 indexed citations

18.

Calabrese, Leonard H., et al.. (2020). Infections in the Era of Targeted Therapies: Mapping the Road Ahead. Frontiers in Medicine. 7. 336–336. 6 indexed citations

19.

Ornstein, Moshe Chaim, Cassandra Calabrese, Laura S. Wood, et al.. (2019). Myalgia and Arthralgia Immune-related Adverse Events (irAEs) in Patients With Genitourinary Malignancies Treated With Immune Checkpoint Inhibitors. Clinical Genitourinary Cancer. 17(3). 177–182. 9 indexed citations

20.

Calabrese, Cassandra, Beth Faiman, David T. Martin, Frederic J. Reu, & Leonard H. Calabrese. (2011). Type 1 Cryoglobulinemia. JCR Journal of Clinical Rheumatology. 17(3). 145–147. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact